Related Experiment Video
Updated: Aug 17, 2026

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression
Y X Zeng1, K Somasundaram, W S el-Deiry
1Howard Hughes Medical Institute, Department of Medicine and Genetics, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Abstract:
The 52-kD Activator Protein (AP2) is a DNA-binding transcription factor implicated in signalling terminal differentiation. Profound developmental abnormalities have been recently observed in AP2-null mice. The molecular events by which AP2 promotes differentiation or development are, however, unknown. Increased expression of the universal cell cycle inhibitor p21WAF1/CIP1 occurs in growth-arrested terminally differentiating cells. In a search for cellular factors that could activate p21 during phorbol ester (TPA)-induced differentiation, we identified AP2 as a regulator of p21 expression. Mutagenesis of an AP2 DNA-binding site within a p21 promoter-luciferase reporter inhibited its activation by either AP2 transfection or TPA stimulation. Endogenous p21 protein levels were elevated and DNA synthesis was inhibited in AP2 versus control vector-transfected cells. Overexpression of AP2 in HepG2 human hepatoblastoma and SW480 human colon adenocarcinoma cells inhibited cell division and stable colony formation. These results link the differentiation-associated factor AP2 to negative cell cycle and growth control, possibly through p21 activation.
Insights
Activator protein AP2 regulates the cell cycle inhibitor p21WAF1/CIP1, promoting cell differentiation. This discovery links AP2 to controlling cell growth and division, offering new insights into developmental processes.
Area of Science:
- Molecular Biology
- Cell Biology
- Developmental Biology
Background:
- Activator Protein AP2 is a DNA-binding transcription factor involved in terminal differentiation.
- AP2-null mice exhibit significant developmental abnormalities, but the underlying molecular mechanisms remain unclear.
- p21WAF1/CIP1, a cell cycle inhibitor, is upregulated in terminally differentiating cells.
Purpose of the Study:
- To investigate the role of AP2 in regulating p21WAF1/CIP1 expression during differentiation.
- To elucidate the molecular mechanisms by which AP2 influences cell cycle control and growth.
Main Methods:
- Utilized a p21 promoter-luciferase reporter assay with AP2 DNA-binding site mutagenesis.
- Transfected cells with AP2 or control vectors.
- Measured endogenous p21 protein levels and DNA synthesis.
- Assessed cell division and colony formation in AP2-overexpressing cancer cell lines (HepG2, SW480).
Main Results:
- Mutagenesis of the AP2 binding site in the p21 promoter abolished activation by AP2 or TPA.
- AP2 transfection led to elevated endogenous p21 protein levels and inhibited DNA synthesis.
- Overexpression of AP2 suppressed cell division and stable colony formation in HepG2 and SW480 cells.
Conclusions:
- AP2 acts as a regulator of p21WAF1/CIP1 expression.
- AP2 links differentiation processes to negative control of the cell cycle and cell growth.
- These findings suggest AP2 plays a critical role in development through p21 activation.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Anaphase Promoting Complex
The Intrinsic Apoptotic Pathway
Inhibition of CDK Activity

